China’s NHSA Issues Guidelines for Neurological Medical Services Pricing
China’s National Healthcare Security Administration (NHSA) has released the “Guidelines for the Pricing Project Initiation...
Policy / Regulatory
Major Policy Directions in China’s Healthcare Arena: A Comprehensive Breakdown
In a momentous address at the Third Session of the 14th National People’s Congress on...
CDE Launches SPARK Project to Boost Pediatric Antitumor Drug R&D
China’s Center for Drug Evaluation (CDE) has released a notification to solicit feedback on its...
National Allied Procurement Office Allows VBP Winners to Adjust MAH and Manufacturing Details
The National Allied Procurement Office has issued a notification clarifying rules for China’s Volume-Based Procurement...
AI in Healthcare: The Impact of DeepSeek Technology and Industry Developments
The integration of advanced AI technologies into healthcare is revolutionizing the industry, and the recent...
In-Depth Analysis of the National Healthcare Security Policy: A Guide to Key Reforms and Implications
The National Healthcare Security Administration (NHSA) has unveiled its 2025 priority action list, focusing on...
State Council’s Draft Plan Boosts Innovative Drug Development via Medical Insurance Reforms
The State Council has released a second draft proposal outlining measures to support the high-quality...
Shanghai Issues Legal Guidebook for Innovative Drug Marketing
The Shanghai Municipal Market Supervision Administration Bureau has delivered a legal guidebook tailored for innovative...
China Outlines Drug Pricing Reforms, Encourages Insurance Funds for Innovation
The Chinese government has released a set of opinions detailing the establishment of a new...
Stabilizing Foreign Investment: China’s Comprehensive Action Plan for 2025
In a significant move to bolster foreign investment and enhance the country’s economic openness, the...
New Guidelines for Advanced Gastric Cancer Drug Development Released in China
The National Medical Products Administration (NMPA) of China has published the “Guidance Principles for Clinical...
NMPA Releases 90th Batch of Reference Drugs for GQCE
The National Medical Products Administration (NMPA) has released the 90th batch of reference drugs for...
China Launches Major Public Health Initiatives to Enhance Healthcare Accessibility
In a bid to bolster public health infrastructure and improve healthcare services, China’s National Health...
Hainan Unveils Biomedical New Technology Policy to Boost Medical Innovation
In-Depth Analysis and Orientation Guide for Hainan’s Biomedical New Technology PolicyThe Hainan Provincial Health Commission,...
Shanghai’s Ambitious Plan to Revolutionize Brain-Computer Interfaces
In-Depth Analysis and Orientation Guide for Shanghai’s Brain-Computer Interface (BCI) PolicyShanghai has unveiled a groundbreaking...
NMPA’s New Guidelines for Drug Registration Review
A Look at the New Rules for Chemical and Biological Drug Filings in China:The Center...
Shanghai’s Three-Year Plan to Boost Elderly Care Quality
A Comprehensive Look at Shanghai’s Efforts to Integrate Medical Care and Elderly Care:The Shanghai Civil...
Tianjin Municipality Boosts Biopharmaceutical Industry with New Measures
An In – Depth Look at Tianjin’s Efforts to Accelerate Medical Innovation and Gather Resources:The...
NMPA Seeks Public Feedback on Export Drug Manufacturing Rules
An In – Depth Look at the New Draft Proposal for the Administration and Management...
China’s Drug Procurement Under Scrutiny: Addressing Quality Concerns and Policy Reforms
An In – Depth Exploration of the Recent Survey on Bulk Drug Procurement in China...